Advertisement

Novel Eco-Friendly Spectrophotometric Determination of Guaifenesin in Pharmaceutical preparations and Environmental Wastewater Samples: Application to content uniformity testing

Research Article | DOI: https://doi.org/DOI:10.31579/2835-8325/184

Novel Eco-Friendly Spectrophotometric Determination of Guaifenesin in Pharmaceutical preparations and Environmental Wastewater Samples: Application to content uniformity testing

  • Nief Rahman Ahmad 1*
  • Ghfran Naif Rahman 2

1College of Environmental, University of Mosul-Iraq.

2Student at Medical College, University of Mosul, Mosul-Iraq. 

*Corresponding Author: Nief Rahman Ahmad, College of Environmental, University of Mosul-Iraq.

Citation: Nief R. Ahmad, Ghfran Naif Rahman, (2025), Novel Eco-Friendly Spectrophotometric Determination of Guaifenesin in Pharmaceutical preparations and Environmental Wastewater Samples: Application to content uniformity testing, Clinical Research and Clinical Reports, 8(4); DOI:10.31579/2835-8325/184

Copyright: © 2025, Nief Rahman Ahmad. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 02 August 2025 | Accepted: 26 August 2025 | Published: 22 September 2025

Keywords: body reactivity; early postnatally

Abstract

A simple, precise, accurate, rapid, economical and sensitive ultraviolet spectrophotometric method has been developed for the determination of guaifenesin in pharmaceutical preparations and environmental wastewater samples, which shows maximum absorbance at 222 nm in water. Beer's law was obeyed in the range of 2-40μg/ ml, with molar absorptivity of 0.75 ×104 L.mol-1.cm-1, relative standard deviation of the method was less than 1.4%, and accuracy (average recovery %) was 100 ± 1.0. No interference was observed from common excipients and additives often accompany with guaifenesin in pharmaceutical preparations. The method was successfully applied to the determination of guaifenesin in some pharmaceutical formulations (Syrups and Tablets) and industrial wastewater samples. The proposed method was validated by sensitivity and precision which proves suitability for the routine analysis of guaifenesin in true samples. Application to content uniformity testing.

Introduction

Guaifenesin is chemically known as 1,2- propanediol3-(2-methoxyphenoxy) (Scheme 1) Guaifenesin occurs as a white crystals or crystalline powder. [1], is an expectorant and widely used in the treatment of coughing and congestion caused by the common cold, bronchitis, and breathing illness.[2], Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus and clear the airways. The usual does is 100 to 200 mg every 2 to 4 hours [3-5].

Molecular formula: C10H14O4 =198.2

Scheme 1.  Chemical   structure of guaifenesin. 

Analytical procedures for the determination of guaifenesin include titrimetric method[1], various spectrophotometric [6-13], HPLC[14-20], electro kinetic chromatography[21], Volta metric assay[22], Capillary gas chromatography[23,24] and ion pair high performance liquid chromatography methods are also reported in the literature for the estimation of guaifenesin[25].The present paper reports the development of a new UV method for determination of guaifenesin in different type of syrups, tablets and environmental water samples. Application to content uniformity testing.

Experimental

Apparatus

Shimadzu UV- 1700 pharmaspec (double beam) spectrophotometer with 1.0 cm quartz cells was used for absorption measurement.

Reagents

All chemical used were of analytical or pharmaceutical grade and guaifenesin standard material was provided from AL-hokamaa company for pharmaceutical industries (HPI) Mosul-Iraq. 

guaifenesin standard solution 10ppm

This solution was prepared by dissolving 10 mg of guaifenesin in 1000 ml of distilled water in calibrated flask. 

Determination of absorption maxima

The standard solution of guaifenesin (20µg/ml) was scanned in the range of 220-300 nm which shows maxima located at 222 nm (Figure.1). Therefore 222 nm wavelength was selected for the construction of calibration curve.

Figure 1: Absorption spectra of 20µg/ml guaifenesin against distilled water. 

Recommended procedure

From the absorption maxima, calibration curve was prepared in the concentration range of 2-40 µg/ml. The absorbance was measured at 222 nm against distilled-water as a blank. The concentration of the sample solution can be determined by using the calibration curve 

Procedures for pharmaceutical preparations (syrups):

Four different marketed guaifenesin syrup formulations (Exidil 30mg/5ml, Pulmocodain 100mg/5ml, Tussilet 50mg/5ml and Bronquium 30mg/5ml) were selected for analysis. The content of 5 bottles of each type were mixed well in 1L dried beaker. Aliquots equivalent to 5 mg of guaifenesin were transferred into 1L volumetric flasks and diluted with distilled water to the volume to get 5µg/ml solution   and aliquot of this solution was treated as described above for recommended procedure and the concentration was calculated by using the calibration curve of this method. 

Procedure for pharmaceutical preparations (Tablets) 

Weight and powder 10 tablets [Brawn tablet of Guaifenesin (100 mg)] Tablets-India]. Dissolve a quantity of the powdered tablets containing 0.01 gm. of guaifenesin in about 100 ml methanol and mixed for 20 mint and then filtered. The filtrate was mad up to 1000 ml with distilled water and aliquot of this solution was treated as described above for recommended procedure and the concentration was calculated by using the calibration curve of this method.

Procedure for real water samples

To demonstrate the practical applicability of the proposed method, real water samples were analyzed by this method. Industrial waste water from AL-hokamaa company for pharmaceutical industries (HPI) Mosul-Iraq, were fortified with the concentrations in the range of 2,4,6 µg/ml of guaifenesin. The fortified water samples were analyzed as described above for recommended procedure and the concentration was calculated by using the calibration curve of this method.

Result and Discussion

UV visible spectrophotometry is still considered to be a convenient and low-cost method for the determination of pharmaceuticals [26-32]. The method used for the determination of guaifenesin in pharmaceutical preparations and environmental wastewater samples was found to be sensitive, simple, accurate, and reproducible. Beer s law was obeyed in the concentration range of 2-40 µg/ml (Figure.2) with correlation coefficient of 0.997, intercept of 0.002 and slope of 0.0375. The conditional molar absorptivity was found to be 0.75x104 l/mol.cm.

Figure 2: Calibration curve for Guaifenesin

Accuracy and precision of the method.

A pure drug solution was analyzed at three different concentrations; each determination being repeated six times. The relative error (%) and relative standard deviation values are summarized in (Table 1). From (table 1) the values of standard deviation were satisfactory and the recovery studies were close to 100%. The RSD% value is less than1.4 indicative of accuracy of the method.

Guaifenesin taken(µg/ml))

Er (%) a

RSD (%)

2

3

6

1.1

1.2

1.12

1.3

41.

1.25

Table I: Accuracy and precision of the proposed method.

The proposed method was compared with other reported UV spectrophotometric methods and found to be superior and more sensitive than other methods (Table 2).

Method 4

Method 3

Method 2

Method 1

Parameters

Proposed

11

8

7

Ref

222

273

274

272

Max(nm)λ

H2O

Methanol

H2O

Methanol

Solvents

2-40

5-40

10 -50

30-150

Linear range µg/ml

0.75 X104

2.973x103

2.378x103

8.72x103

(l/mol.cm)ɛ

Less than 1.4

0.74

----­­­

Less than 2

RSD%

Syrups, Tablets and industrial wastewater

Tablets

Tablets

Tablets

Application

Table 2: Comparison of the existing UV spectrophotometric methods with the proposed method for guaifenesin.

Analytical application             

The proposed method was satisfactorily applied to the determination of guaifesein in its pharmaceutical preparations syrups, Tablets and wastewater samples, the results of the assay of the pharmaceutical preparations revels that there is close agreement between the results obtained by the proposed 

method and the label claim (Table3), and the results of water samples (Table 4) show that the recovery values obtained were closed to 100%.                 

Label amount

Proposed method found*

Pharmaceutical formulations

6 mg/ml

20 mg/ml

10 mg/ml

6.0mg/ml

100mg/Tablet

6.03mg/ml

19.97 mg/ml

10.05 mg/ml

6.0 mg/ml

9.99

Exidil syrup (HPI) 

Pulmocodin syrup (NDI)

Tussilet syrup (HPI) 

Bronquium(Ferrer)

Tablets(100mg) (Brawn-India)

*Mean of five determinations

Table 3: Determination of guaifenesin formulations

Wastewater samples

Added µg/ml

Found* µg/ml

Recovery %(n=10)

Industrial wastewater

2

4

6

2.02

3.97

6.05

101

      99.25

       100.833

* Mean value of ten determinations.

Table 4: Determination of guaifenesin in industrial wastewater samples

Application of the method to content uniformity [33-37]

The proposed method proved to be suitable for the content uniformity test, where a great number of assays on individual tablets are required. Data presented in Table [5] indicate that the proposed method can accurately and precisely quantitate guifenesin in its commercially available tablets. The mean percentage (with RSD) of the labeled claim found in ten tablets was (0.14%) which fall within the content uniformity limits specified by the USP 33 [ 33].

Table [4]: Content uniformity testing of guifenesin tablets using the proposed method                                                                                                               

% of the label claim

Tablet NO. 1

Tablet NO. 2

Tablet NO. 3

Tablet NO. 4

Tablet NO. 5

Tablet NO. 6

Tablet NO. 7

Tablet NO. 8

Tablet NO. 9

  Tablet NO. 10

 

                         % RSD 

                    Max. allowed unit [33]

100. 16

100. 23

99. 88

100.41

99.38

99. 53

99.82

100. 15

100.26

100.16

99.998

0.41

±1.4%

Conclusion 

The developed method is found to be highly sensitive, accurate, simple, precise and economical, and can be used for routine quality control analysis of guifenesin in pure form, bulk, pharmaceutical formulations and environmental wastewater samples   

Acknowledgments

The author wishes to express gratitude to AL-hokamaa company for pharmaceutical industries (HPI) Mosul-Iraq, for providing gift samples of guaifenesin standard materials and syrups.

References

Clinical Trials and Clinical Research: I am delighted to provide a testimonial for the peer review process, support from the editorial office, and the exceptional quality of the journal for my article entitled “Effect of Traditional Moxibustion in Assisting the Rehabilitation of Stroke Patients.” The peer review process for my article was rigorous and thorough, ensuring that only high-quality research is published in the journal. The reviewers provided valuable feedback and constructive criticism that greatly improved the clarity and scientific rigor of my study. Their expertise and attention to detail helped me refine my research methodology and strengthen the overall impact of my findings. I would also like to express my gratitude for the exceptional support I received from the editorial office throughout the publication process. The editorial team was prompt, professional, and highly responsive to all my queries and concerns. Their guidance and assistance were instrumental in navigating the submission and revision process, making it a seamless and efficient experience. Furthermore, I am impressed by the outstanding quality of the journal itself. The journal’s commitment to publishing cutting-edge research in the field of stroke rehabilitation is evident in the diverse range of articles it features. The journal consistently upholds rigorous scientific standards, ensuring that only the most impactful and innovative studies are published. This commitment to excellence has undoubtedly contributed to the journal’s reputation as a leading platform for stroke rehabilitation research. In conclusion, I am extremely satisfied with the peer review process, the support from the editorial office, and the overall quality of the journal for my article. I wholeheartedly recommend this journal to researchers and clinicians interested in stroke rehabilitation and related fields. The journal’s dedication to scientific rigor, coupled with the exceptional support provided by the editorial office, makes it an invaluable platform for disseminating research and advancing the field.

img

Dr Shiming Tang

Clinical Reviews and Case Reports, The comment form the peer-review were satisfactory. I will cements on the quality of the journal when I receive my hardback copy

img

Hameed khan